1.
European Journal of Clinical Pharmacology
; 78(SUPPL 1):S100-S101, 2022.
Article
in English
| Web of Science | ID: covidwho-1913008
2.
The Lancet
; 2020.
Article
| WHO COVID | ID: covidwho-260016
ABSTRACT
BackgroundConcerns have been raised about the possibility that inhibitors of the renin?angiotensin?aldosterone system (RAAS) could predispose individuals to severe COVID-19;however, epidemiological evidence is lacking. We report the results of a case-population study done in Madrid, Spain, since the outbreak of COVID-19.